{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:23:35Z","timestamp":1773282215462,"version":"3.50.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1097\/iae.0b013e3181babdf1","type":"journal-article","created":{"date-parts":[[2009,11,3]],"date-time":"2009-11-03T08:19:15Z","timestamp":1257236355000},"page":"1418-1423","source":"Crossref","is-referenced-by-count":16,"title":["INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO PRESUMED OCULAR HISTOPLASMOSIS SYNDROME"],"prefix":"10.1097","volume":"29","author":[{"given":"RITA","family":"EHRLICH","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"THOMAS A.","family":"CIULLA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RAJ","family":"MATURI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NISHA S.","family":"KHERADIYA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NICK","family":"HRISOMALOS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHIRI","family":"SHULMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MATTHEW G.","family":"GUESS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ELLEN","family":"COYLE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ALON","family":"HARRIS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210130","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0161-6420(96)30515-0","article-title":"Etiology of choroidal neovascularization in younger patients.","volume":"103","author":"Cohen","year":"1996","journal-title":"Ophthalmology"},{"key":"R2-5-20210130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1056\/NEJM200002173420707","article-title":"Age-related macular degeneration.","volume":"342","author":"Fine","year":"2000","journal-title":"N Engl J Med"},{"key":"R3-5-20210130","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/00055735-200112000-00009","article-title":"Presumed ocular histoplasmosis syndrome: update on epidemiology, pathogenesis, and photodynamic, antiangiogenic, and surgical therapies.","volume":"12","author":"Ciulla","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"R4-5-20210130","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/S0161-6420(84)34113-6","article-title":"Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome. Visual prognosis.","volume":"91","author":"Olk","year":"1984","journal-title":"Ophthalmology"},{"key":"R5-5-20210130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00006982-198808040-00001","article-title":"Subfoveal neovascularization in the ocular histoplasmosis syndrome: a natural history study.","volume":"8","author":"Kleiner","year":"1988","journal-title":"Retina"},{"key":"R6-5-20210130","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1001\/archopht.1987.01060110045029","article-title":"Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial. Macular Photocoagulation Study Group.","volume":"105","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"R7-5-20210130","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration.","volume":"355","author":"Brown","year":"2006","journal-title":"N Engl J Med"},{"key":"R8-5-20210130","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age related macular degeneration.","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"R9-5-20210130","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.ophtha.2007.03.043","article-title":"Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.","volume":"114","author":"Chan","year":"2007","journal-title":"Ophthalmology"},{"key":"R10-5-20210130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/bjo.2006.099887","article-title":"Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia.","volume":"91","author":"Sakaguchi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R11-5-20210130","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/archopht.125.11.1487","article-title":"Intravitreal bevacizumab for subfoveal idiopathic choroidal neovascularization.","volume":"125","author":"Mandal","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"R12-5-20210130","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/IAE.0b013e31815e9834","article-title":"Intravitreal bevacizumab (Avastin) injection as primary treatment of inflammatory choroidal neovascularization.","volume":"27","author":"Ad\u00e1n","year":"2007","journal-title":"Retina"},{"key":"R13-5-20210130","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/archopht.1991.01080090066027","article-title":"Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Macular Photocoagulation Study Group.","volume":"109","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"R14-5-20210130","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archopht.1989.01070010354023","article-title":"Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Macular Photocoagulation Study Group.","volume":"107","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"R15-5-20210130","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/archopht.122.11.1597","article-title":"Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic. I. Ophthalmic finding from a randomized clinical trail: Submacular Surgery Trails (SST) Group H trail: SST Report no 9.","volume":"122","author":"Davidorf","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"R16-5-20210130","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9394(03)00389-1","article-title":"Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndrome.","volume":"136","author":"Rechtman","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R17-5-20210130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00006982-200501000-00003","article-title":"Photodynamic therapy for juxtafoveal choroidal neovascularization due to ocular histoplasmosis syndrome.","volume":"25","author":"Shah","year":"2005","journal-title":"Retina"},{"key":"R18-5-20210130","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00006982-200412000-00004","article-title":"Photodynamic therapy of subfoveal and juxtafoveal choroidal neovascularization in ocular histoplasmosis syndrome: a retrospective case series.","volume":"24","author":"Liu","year":"2004","journal-title":"Retina"},{"key":"R19-5-20210130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00006982-200306000-00003","article-title":"Ocular photodynamic therapy with verteporfin for choroidal neovascularization secondary to ocular histoplasmosis syndrome.","volume":"23","author":"Busquets","year":"2003","journal-title":"Retina"},{"key":"R20-5-20210130","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0161-6420(02)01103-X","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series.","volume":"109","author":"Saperstein","year":"2002","journal-title":"Ophthalmology"},{"key":"R21-5-20210130","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.ophtha.2004.02.014","article-title":"Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled open label 2-year study.","volume":"111","author":"Rosenfeld","year":"2004","journal-title":"Ophthalmology"},{"key":"R22-5-20210130","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/j.ophtha.2006.07.003","article-title":"Verteporfin therapy for CNV secondary to OHS.","volume":"113","author":"Saperstein","year":"2006","journal-title":"Ophthalmology"},{"key":"R23-5-20210130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bjo.2004.046623","article-title":"Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression.","volume":"89","author":"Leslie","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R24-5-20210130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00006982-200501000-00004","article-title":"Photodynamic therapy with verteporfin for peripapillary choroidal neovascularization.","volume":"25","author":"Rosenblatt","year":"2005","journal-title":"Retina"},{"key":"R25-5-20210130","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3928\/15428877-20060501-01","article-title":"Photodynamic therapy in young patients.","volume":"37","author":"Lam","year":"2006","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R26-5-20210130","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archopht.118.3.327","article-title":"A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.","volume":"118","author":"Sickenberg","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"R27-5-20210130","doi-asserted-by":"crossref","first-page":"198","DOI":"10.47102\/annals-acadmedsg.V35N3p198","article-title":"Photodynamic therapy for choroidal neovascularisation secondary to inflammatory chorioretinal disease.","volume":"35","author":"Lim","year":"2006","journal-title":"Ann Acad Med Singapore"},{"key":"R28-5-20210130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0002-9394(02)01936-0","article-title":"Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy.","volume":"135","author":"Moshfeghi","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R29-5-20210130","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00417-007-0637-y","article-title":"Intravitreal bevacizumab as initial treatment for choroidal neovascularization associated with presumed ocular histoplasmosis syndrome.","volume":"245","author":"Ad\u00e1n","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R30-5-20210130","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ajo.2007.12.030","article-title":"Intravitreal bevacizumab for choroidal neovascularization in ocular histoplasmosis.","volume":"145","author":"Schadlu","year":"2008","journal-title":"Am J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006982-200911000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T11:09:37Z","timestamp":1685185777000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-200911000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3181babdf1","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}